• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Can Trianim get any worse?

Anonymous

Guest
We lost Smiths DHD and Acapella, nobody is keeping or buying Vapotherm, Ventlab is recalled and nothing changes! We cannot just ride aerogen and Monaghan. Wake up! We need to focus on bringing in specialty products or it's over.